Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer

Trastuzumab is commonly used in the treatment of human epidermal growth factor receptor-2 positive (HER-2+) breast cancer, but its efficacy is often limited by the emergence of chemoresistance. Recent studies indicate that exosomes act as vehicles for exchange of genetic cargo between heterogeneous...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Mingli, Hu, Jianguo, Lu, Pengwei, Cao, Hui, Yu, Chao, Li, Xiangke, Qian, Xueke, Yang, Xue, Yang, Yunqing, Han, Na, Dou, Dongwei, Zhang, Fan, Ye, Mulin, Yang, Changcheng, Gu, Yuanting, Dong, Huaying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976584/
https://www.ncbi.nlm.nih.gov/pubmed/31969559
http://dx.doi.org/10.1038/s41419-020-2250-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976584/
https://www.ncbi.nlm.nih.gov/pubmed/31969559
http://dx.doi.org/10.1038/s41419-020-2250-5

Ejemplares similares